Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Key Highlights
- ➤Facility relocation completed from Mountain View to San Jose
- ➤Relocation expected to generate approximately $0.6 million in annualized cost savings
- ➤Company anticipates further savings opportunities as transition fully integrates
- ➤New facility expected to improve operational efficiency and support future growth
Expert Statements
Patrick Mercer, President and CEO of Iridex
“We are pleased to announce the successful relocation of our manufacturing facility. This was a key component of our plan to reduce expenses and improve profitability”
Patrick Mercer, President and CEO of Iridex
“This relocation is expected to improve operational efficiency while providing the infrastructure required to support the business we are building for the future.”
SAN JOSE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced that it has completed the relocation of its manufacturing facility from Mountain View, California to a new facility in San Jose, California.
“We are pleased to announce the successful relocation of our manufacturing facility. This was a key component of our plan to reduce expenses and improve profitability,” said Patrick Mercer, President and CEO of Iridex. “This relocation is expected to improve operational efficiency while providing the infrastructure required to support the business we are building for the future.”
Get started
Create a free account to read the full story.